Quipt Home Medical Target of Unusually High Options Trading (NASDAQ:QIPT)

Quipt Home Medical Corp. (NASDAQ:QIPT) saw unusually large options trading activity on Monday. Stock investors acquired 5,781 call options on the company. This is an increase of 1,283% compared to the average daily volume of 418 call options.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on QIPT shares. Canaccord Genuity Group raised their price objective on shares of Quipt Home Medical from $1.70 to $2.30 and gave the company a “hold” rating in a research note on Tuesday, August 19th. Benchmark reaffirmed a “buy” rating on shares of Quipt Home Medical in a research note on Tuesday. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Quipt Home Medical in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $3.15.

Quipt Home Medical Trading Up 0.6%

Quipt Home Medical stock opened at $3.52 on Wednesday. The firm has a market cap of $152.91 million, a price-to-earnings ratio of -14.08 and a beta of 0.59. Quipt Home Medical has a 1 year low of $1.35 and a 1 year high of $3.54. The firm’s 50 day moving average price is $2.47 and its two-hundred day moving average price is $2.32. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.75 and a current ratio of 1.15.

Quipt Home Medical (NASDAQ:QIPT) last announced its quarterly earnings data on Monday, December 15th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.11). The company had revenue of $68.30 million for the quarter, compared to analyst estimates of $87.46 million. Quipt Home Medical had a negative net margin of 4.38% and a negative return on equity of 10.32%. On average, research analysts predict that Quipt Home Medical will post -0.05 EPS for the current fiscal year.

Hedge Funds Weigh In On Quipt Home Medical

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Kanen Wealth Management LLC boosted its holdings in shares of Quipt Home Medical by 108.4% in the first quarter. Kanen Wealth Management LLC now owns 2,969,541 shares of the company’s stock worth $6,919,000 after buying an additional 1,544,529 shares during the period. Pale Fire Capital SE purchased a new stake in shares of Quipt Home Medical in the 1st quarter valued at approximately $574,000. Nuveen LLC purchased a new stake in shares of Quipt Home Medical in the 1st quarter valued at approximately $350,000. Strs Ohio acquired a new position in Quipt Home Medical in the 1st quarter worth approximately $452,000. Finally, Russell Investments Group Ltd. grew its position in Quipt Home Medical by 6.5% during the 1st quarter. Russell Investments Group Ltd. now owns 969,822 shares of the company’s stock worth $2,260,000 after purchasing an additional 59,204 shares in the last quarter. Institutional investors and hedge funds own 42.85% of the company’s stock.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.